I think only potential issue is when the phase 3 for PMS will commence?
From JP interviews, it seems he is very confident the phase 3 trial for PMS will start in mid year.
The Type-C meeting with FDA is scheduled early April, so only about two weeks away.
A Type C meeting is a formal interaction where a sponsor, usually a pharmaceutical or biotech company, can discuss specific issues related to developing or reviewing a drug or biological product with the FDA. Unlike Type A meetings (for critical issues like safety) or Type B meetings (for specific review milestones), Type C meetings cover other topics, such as scientific questions, protocol changes, or data interpretations. These meetings help guide the drug development process but are generally confidential.
NEU Price at posting:
$12.59 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)